期刊文献+

益心舒胶囊治疗冠心病稳定型心绞痛的疗效观察 被引量:15

Efficacy of Yi-xin-shu Capsule on Treating Stable Angina Deficiency of Both Qi and Yin and Stagnant Blood
下载PDF
导出
摘要 目的:观察益心舒胶囊对冠心病稳定型心绞痛(气阴两虚兼血瘀型)患者症状及证候疗效的影响。方法:将符合标准的40例患者随机分为对照组和治疗组,每组20例。在西医规范化治疗基础上,对照组加服复方丹参滴丸,治疗组加服益心舒胶囊,疗程均为6个月。观察对照组和治疗组中医证候的变化,分别于治疗前后进行统计学比较。结果:在改善患者心绞痛疗效、心电图疗效、硝酸甘油停减率方面,两组比较差异无统计学意义(P>0.05);与对照组相比,治疗组在改善患者中医证候疗效方面效果显著,差异有统计学意义(P<0.05)。结论:益心舒胶囊治疗冠心病稳定型心绞痛疗效确切,尤其针对属气阴两虚兼血瘀型患者,在改善患者中医证候方面效果显著。 To observe the clinical efficacy of Yi -xin -shu capsule on stable angina (Deficiency of both qi and yin and stagnant blood).Method:Divide 40 patients into a control group and a treatment group randomly .In the control group, the treatment was based on the basis plus compound Danshen dropping pills .In the treatment group, the treatment was based on the basis plus Yi -xin -shu capsules.Six months was as a course.Observe the angina pectoris, ECG, the stop -reducing rate of nitroglycerin, TCM symptom and TCM syndrome score .Results:There was no significant differ-ence between two groups in angina pectoris , ECG and the stop -reducing rate of nitroglycerin(P &gt;0.05).The effect in treatment group was significant for TCM syndrome patients (P &lt;0.05).Conclusion:Yi -xin -shu capsule is effective on treating stable angina especially in TCM syndrome for deficiency of both qi and yin and stagnant blood .
出处 《中医药学报》 CAS 2014年第4期177-179,共3页 Acta Chinese Medicine and Pharmacology
关键词 冠心病 心绞痛 益心舒胶囊 Coronary heart disease Angina Clinical observation Traditional Chinese medicine
  • 相关文献

参考文献12

  • 1王永炎.中医内科学[M].上海:上海科学技术出版社,2000.132-136.
  • 2中国中西医结合学会心血管病专业委员会.冠心病中医辨证标准[J].中西医结合杂志,1991,11(5):257-258.
  • 3陈濒珠.内科学[M].3版.北京:人民卫生出版社,1995:263-264.
  • 4国际心脏病学会和协会及世界卫生组织临床命名标准化专题组.缺血性心脏病的命名及诊断标准[J].中华心血管病杂志,1981,(9):75-76.
  • 5无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2065
  • 6陈可冀.心脑血管疾病研究[M].上海:上海科学技术出版社,1991.303.
  • 7沈绍功,姚金城.中医心病之心绞痛诊断与疗效标准[J].中国医药学报,2004,19(10):581-583. 被引量:126
  • 8郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,1993.70.
  • 9叶任高,陆再英.内科学[M].北京:人民卫生出版社,1994:993.
  • 10秦建国.胸痹心痛病机新论[J].辽宁中医杂志,2004,31(10):815-816. 被引量:10

二级参考文献54

  • 1穆文华.细辛用量研究初探[J].医药世界,2007(S1):106-107. 被引量:9
  • 2叶任高.内科学[M](第5版)[M].北京:人民卫生出版社,2000.313.
  • 3Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology, 2000,94 ( 1 ) :31-35.
  • 4Ryden L, Standl E, Bartnic M, et al. Guideline on diabetes, prediabetes and cardiovascular disease:executive summary. The Task Force on Diabetes and Cardiovascular Disease of European Society of Cardiology (ESC) and of the Euopean Association for the Study of Diabetes(EASD). Eur Heart J,2007,28( 1 ) :88-136.
  • 5Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology.J Am Coll Cardiol,1999,34(3) :912-948.
  • 6Campeau L. Letter: Grading of angina pectoris. Circulation 1976 :54(3) :522-523.
  • 7O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol, 2000,36(1) :326-340.
  • 8Gibbons Pal, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-sunanary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol, 2003,41 ( 1 ) : 159-168.
  • 9Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 2004,110(10) :1245-1250.
  • 10Girman CJ, Rhodes T, Mercuri M,et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherescleresis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol,2004,93 ( 2 ) : 136-141.

共引文献2639

同被引文献154

引证文献15

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部